Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeSCIEXSCIEX Presents Clinical Solutions for Routine Diagnostics and Innovative Research at AACC

SCIEX Presents Clinical Solutions for Routine Diagnostics and Innovative Research at AACC

New Topaz™ Prep Station and FDA-approved Vitamin D 200A Assay Kit streamline workflows to simplify sample prep, improving ROI

SCIEX, a global leader in life science analytical technologies, advanced the accessibility of mass spectrometry in the clinical setting with new product introductions at AACC 2018. These products add to SCIEX’s existing industry leading solutions and services, to deliver the power of mass spectrometry to clinical laboratories performing routine diagnostic assays and innovative clinical research applications.

Today, SCIEX announced the launch of the new Topaz™ Prep Station, an automated sample preparation workstation that is ideal for labs managing high daily sample volumes. The Topaz Prep Station supports the Topaz™ LC-MS/MS System, a Class I Medical Device designed to simplify adoption for new mass spectrometry users, while still offering the functionality needed for more advanced users.

Along with the Topaz Prep Station, SCIEX also announced the introduction of the new FDA-approved Vitamin D 200A Assay Kit. This kit is a locked, pre-validated assay that allows labs to perform vitamin D analysis in-house, and employs automated sample preparation on the Topaz Prep Station to deliver highly accurate results to support medical decisions and quality patient care.

Together, the Topaz Prep Station and the Vitamin D 200A Assay Kit enables clinical diagnostic testing labs to:

  • Increase laboratory productivity – fully automated, “walk-away” sample preparation frees up laboratory staff to perform other tasks
  • Further reduce sample preparation times and streamline workflows, with the pre-developed FDA-approved assay kit
  • Provide more consistent and accurate results, and minimize human error due to connectivity with the Topaz LC-MS/MS System
  • Easily handle large sample volumes — ideal for busy laboratories
  • Ensure continuous sample tracking, via tube and plate barcode scanning

The Topaz System makes the move to mass spectrometry simple and efficient by providing clinical diagnostics laboratories a complete LC-MS/MS package, with an easy-to-use, intuitive user interface that allows users to build proficiency quickly.

“We are excited to offer our latest developments, designed to bring the reliability and accuracy of LC-MS/MS to clinical labs,” said Aaron Hudson, Vice President of Global Marketing and Clinical Diagnostics at SCIEX. “While supporting our rapidly growing portfolio of innovative solutions, SCIEX aspires to provide cutting edge technology while reducing the complexity for the user.”

Earlier this year, SCIEX launched the Citrine™ MS/MS system, the front-line alternative for clinical diagnostics. With its unique combination of sensitivity and speed, the Citrine system enables trace level analysis, comprehensive panels and the measurement of both large and small molecules.

At AACC, SCIEX will showcase the Topaz LC-MS/MS System, the Topaz Prep Station and the Citrine MS/MS medical devices at booth #3909. In addition to its medical devices portfolio, SCIEX will feature clinical research innovations and workflows that support efforts in biomarker discovery and validation, recognizing that new biomarkers today could be applied as routine diagnostic assays of the future. SCIEX’s partnership with Phenomenex, a global leader in separation science techniques, also leads to a wide range of workflow and data quality-enhancing solutions, which will be displayed at the booth.

Throughout the week, experts from SCIEX will provide a series of in-booth seminars and a round table discussion on how mass spectrometry technology can be seamlessly adopted in any clinical lab. For more information, please visit https://sciex.com/events/aacc-2018.

*Not available in all countries. Only available in the US.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy